2 Result: Alvotech
Alvotech, Teva, JNJ Settle on AVT04; Teck Resources Evaluating Glencore Proposal
June 12th, 2023
Alvotech (Nasdaq: ALVO) and an affiliate of Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) have announced a settlement and license agreement with Johnson & Johnson (NYSE: JNJ) concerning AVT04, Alvotech's proposed biosimilar to Stelara (ustekinumab. Read more
The Week On The Horizon: Brady Corporation, Canadian Solar, Canada Goose, Alvotech
May 14th, 2023
On Thursday, May 18, investors and analysts will be keeping a close eye on several notable companies set to report their financial results. Brady Corporation (NYSE: BRC) is expected to release its fiscal 2023 third quarter financial results . Read more
Want To Find Some News?
News By Industries
Recent Post
-
Treasury Targets Global Scam Networks and the Corporate Infrastructure That Enables Them
November 06th, 2026FDA Grants Accelerated Approval to a New Treatment for Head and Neck Squamous Cell Carcinoma
November 05th, 2026New Details Emerge in Amazon Ads Auction-Rigging Case
November 05th, 2026November 02nd, 2026
Member Login